Insider Trading April 10, 2026 05:34 PM

Limbach CFO sells 4,207 shares under 10b5-1 plan, totaling $358,341

Jayme Brooks executed planned stock sales amid mixed fourth-quarter results and analyst optimism on margins and project pipeline

By Leila Farooq LMB
Limbach CFO sells 4,207 shares under 10b5-1 plan, totaling $358,341
LMB

Limbach Holdings Chief Financial Officer Jayme L. Brooks disposed of 4,207 shares of company stock on April 8 and April 9, 2026 under a 10b5-1 trading plan, generating $358,341 in proceeds. The transactions, disclosed via an SEC Form 4, came as the company reported a fourth-quarter EPS beat but revenue below expectations and as Stifel kept a Buy rating while raising its price target.

Key Points

  • Limbach CFO Jayme L. Brooks sold 4,207 shares on April 8 and April 9, 2026 under a 10b5-1 plan, totaling $358,341 in proceeds.
  • After the transactions, Brooks directly owns 136,543 shares and indirectly holds 3,897 shares through the Brooks Family Trust; the filings were disclosed via SEC Form 4.
  • Limbach posted a fourth-quarter EPS of $1.40, beating the $1.21 estimate by 15.7 percent, but revenue of $186.9 million fell short of the $198.45 million expectation; Stifel maintained a Buy rating and raised its price target to $107, citing strong margins and growth from national account and data center work.

Jayme L. Brooks, Chief Financial Officer of Limbach Holdings, Inc. (NASDAQ:LMB), sold a total of 4,207 shares of common stock across multiple trades on April 8 and April 9, 2026, according to a Form 4 filed with the Securities and Exchange Commission.

The dispositions were carried out under a 10b5-1 trading plan that Brooks adopted on December 16, 2025. The combined sales produced proceeds of $358,341.

Trade details disclosed in the filing show that on April 8 Brooks sold 3,366 shares in several transactions at prices ranging from $85.00 to $85.54, with a weighted average price of $85.1942. On April 9 she sold 841 shares, also in multiple trades, at prices between $85.00 and $85.50, with a weighted average price of $85.11.

At the time of reporting the company's common shares were trading at $82.59, a level below the prices at which Brooks executed the April trades.


Post-transaction holdings

Following the sales, Brooks directly holds 136,543 shares of Limbach. The Form 4 also indicates indirect ownership of 3,897 shares through the Brooks Family Trust.


Valuation snapshot

InvestingPro analysis cited in the disclosure states that Limbach appears undervalued at current market levels, noting a market capitalization of $986 million and a price-to-earnings ratio of 25.85. The filing also references InvestingPro offerings, noting that subscribers have access to additional tips and comprehensive Pro Research Reports covering this and more than 1,400 other U.S. equities.


Recent financials and analyst reaction

Limbach reported fourth-quarter results for fiscal 2025 that showed a mixed operating picture. The company posted earnings per share of $1.40, beating consensus analyst expectations of $1.21, a surprise of 15.7 percent. Revenue for the quarter was $186.9 million, however, below the anticipated $198.45 million, a shortfall of 5.82 percent.

Despite the revenue miss, Stifel maintained a Buy rating on Limbach and increased its price target from $104 to $107, citing stronger-than-expected margins and bottom-line performance in the fourth quarter of fiscal 2025. Stifel said it reaffirmed its view following conversations with Limbach's CEO and CFO and highlighted growth opportunities from national account work and data center projects, which the analysts expect will contribute meaningfully to earnings in coming years.


Investor takeaway

The SEC filing documents a planned, prearranged sale by the company's finance chief and leaves intact Brooks' substantial direct and indirect holdings. The trade details, current market price, valuation metrics from InvestingPro, and recent quarterly results together offer investors updated data points on insider activity, company fundamentals, and analyst positioning.

Risks

  • Scheduled insider sales under a 10b5-1 plan introduce near-term selling activity that market participants may monitor; this affects investor sentiment in the equities market.
  • The company reported a revenue shortfall versus expectations for the fourth quarter of fiscal 2025, which presents an execution risk for near-term top-line performance in project-driven segments such as national accounts and data center activity.
  • Valuation viewpoints differ: InvestingPro flagged Limbach as appearing undervalued based on a $986 million market cap and a P/E of 25.85, which highlights uncertainty between market pricing and some analytics providers' assessments in the equity markets.

More from Insider Trading

Photronics CEO Disposes of $5.2M in Stock as Shares Near Yearly High Apr 10, 2026 Broadcom ISG President Disposes $10.6M in Shares Over Two Days Apr 10, 2026 Adaptive Biotechnologies CPO Sells $340K in Stock as Shares Slip; Options Also Exercised Apr 10, 2026 Adaptive Biotechnologies CSO Disposes of $148,500 in Shares Ahead of Price Drop Apr 10, 2026 Whitehawk Therapeutics CEO Sells $49,010 in Stock to Cover RSU Taxes Apr 10, 2026